Sign in
CompletedNo phase

Maternal Brain Imaging in Opioid Use Disorder

Key facts

Who runs it
Indiana University
Where
Indianapolis, United StatesSee the site
Trial code
Status
Completed
People taking part
45 people enrolled
Started
15 Aug 2023
Ended
31 Oct 2025
Type of study
Observational, 2 groups
Treatments tested
  • Buprenorphine
  • Maternal Brain MRI
  • Blood Samples
  • Questionnaires
Record updated
22 May 2026

Who can take part

Age
18 years to 100 years
Sex
Women only
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 20 criteriaShow less

Who can take part

  • Age: >18 years old
  • Any subject that is currently on Buprenorphine at time of screening
  • Singleton pregnancy

Who cannot take part

  • Serious maternal medical illness
  • HIV or AIDs
  • Known or suspected major fetal congenital abnormalities; Pregnant Women with no history of OUD; Inclusion:
  • Serious maternal medical illness
  • HIV or AIDS
  • Age: >18 years old
  • Polysubstance use
  • Score >9 on the PHQ-9, and score >0 on item 9 which is about suicidality
  • Score of 8 or more on GAD-7
  • Any contraindications for MRI
  • Singleton pregnancy; Exclusion:
  • Score of >9 on the PHQ-9, and a score of >0 on item 9 which is about suicidality
  • Score of 8 or more on GAD-7
  • Known or suspected major fetal congenital abnormalities
  • Any contraindications for MRI
  • Opioid or polysubstance abuse as identified on urine screening

Other criteria

  • Pregnant Women with OUD

Where in United States

  • Riley Hospital for ChildrenIndianapolis, United States

About the trial

What the trial wants to find out

This research study aims to learn more about opioid use disorder (OUD) during pregnancy and how outcomes for pregnant women and their newborns can be improved. During pregnancy, people with OUD are prescribed medication-assisted therapy (MAT). The investigators are interested to know how the medication is broken down by the body during pregnancy and how effective it is. The investigators also want to learn if this medication and OUD have any effect on the different parts of the brain when compared to mothers without OUD.

The 2 groups in the trial

  • Pregnant Mothers with Opioid Use Disorder

    Planned recruitment of 20 mothers with Opioid Use Disorder who are on Buprenorphine at the time of screening.

    Treatment: Buprenorphine, Maternal Brain MRI, Blood Samples, and Questionnaires

  • Pregnant Mothers

    Planned recruitment of 20 mothers who do not have any history of opioid use disorder.

    Treatment: Maternal Brain MRI and Questionnaires

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
22 May 2026